c-Rel regulation of the cell cycle in primary mouse B lymphocytes

International Immunology

Volumn 14, Issue 8, 2002, Pages 905-916

  Hsia, Constance Y ^a   Cheng, Shuhua ^a   Owyang, Alexander M ^a   Dowdy, Steven F ^b   Liou, Hsiou Chi ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antigen receptor; B cell; c Rel knockout; Cyclin; NF B

Indexed keywords

BCR ABL PROTEIN; CYCLIN D3; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN P130; PROTEIN P27; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR REL; CDK4 PROTEIN, MOUSE; CDK6 PROTEIN, MOUSE; CDKN1B PROTEIN, MOUSE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE TARGETING; HUMORAL IMMUNITY; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPLEEN CELL; WILD TYPE; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL DIVISION; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; B-LYMPHOCYTES; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN E; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; G1 PHASE; GENES, REL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; RETINOBLASTOMA PROTEIN; S PHASE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 0035993994     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxf055     Document Type: Article

References (54)

1. Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors
2. Induction of cell cycle regulatory proteins in antiimmunoglobulin-stimulated mature B lymphocytes
3. Antigen receptor signaling: Integration of protein tyrosine kinase functions
4. Inducible nuclear expression of NF-κB in primary B cells stimulated through the surface Ig receptor
5. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system
6. NF-kappa B: Ten years after
7. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses
8. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching
9. -/- double-knockout mice
10. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function
11. c-Rel is essential for B lymphocyte survival and cell cycle progression
12. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression
13. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells
14. 1-to-S-phase transition
15. 1-phase progression
16. 1 cyclin-dependent kinase complexes in vivo
17. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
18. 1
19. The retinoblastoma protein and cell cycle control
20. Distinct roles for E2F proteins in cell growth control and apoptosis
21. 1/S-regulatory genes
22. E2F target genes and cell-cycle checkpoint control
23. Regulation of the cyclin E gene by transcription factor E2F1
24. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein
25. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site
26. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression
27. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter
28. Monoclonal antibodies to murine CD40 define two distinct functional epitopes
29. D-type cyclin-dependent kinase activity in mammalian cells
30. Functional interactions of the retinoblastoma protein with mammalian D- type cyclins
31. KIP1 induces cell migration
32. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis
33. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4
34. A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2-, IL-4-, or IL-10-mediated human B cell proliferation
35. 1 cell cycle stage following delivery of complete versus partial activation stimuli
36. kip1 cyclin-dependent kinase inhibitor expression during IL-4-mediated human B cell activation
37. kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation
38. The transcription factor E2F-1 mediates the autoregulation of RB gene expression
39. The regulation of E2F by pRB-family proteins
40. Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16
41. In vivo protein transduction: Delivery of a biologically active protein into the mouse
42. Characterization of the mouse cyclin D3 gene: Exon/intron organization and promoter activity
43. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells
44. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization
45. Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest
46. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27
47. Kip1
48. Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing
49. 1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome
50. 1 to S cell-cycle transition
51. Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression
52. STAT3 is required for the gp130-mediated full activation of the c-myc gene
53. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F
54. IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control